Selling pressure persisted at the Pakistan Stock Exchange (PSX), with the benchmark KSE-100 Index shedding nearly 600 points during the opening minutes of trading on Friday. At 9:35am, the benchmark ...
Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...
Everyday Health on MSN
A drug combo that includes a GLP-1 may improve psoriasis and psoriatic arthritis symptoms
The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity and inflammation together.
PSO provided an update to 10 Tampa Bay News that the report of a weapon "appear to be a hoax" after searching throughout the school, unable to find one.
Pakistan’s mutual fund industry hits a record Rs. 4.317 trillion AUM in January 2026, with equity funds rising 11% and top holdings concentrated in leading blue-chip stocks.
Marta made her FIFA Women’s World Cup debut in the United States in 2003, and immediately announced herself on the global stage with three goals. Brazil were eventually knocked out by Sweden in the ...
The Nation (PK) on MSN
Shoaib, Aqeel, Mudassir advance in the PSO ranking tennis championship
Muhammad Shoaib, Aqeel Khan and Mudassir Murtaza advanced in the PSO National Ranking Tennis Championship 2026. In the men's singles quarterfinals, Mu-hammad Sohaib defeated Muzammil Murtaza 6-3, 6-1, ...
New findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz) and tirzepatide (Zepbound) results ...
Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for patients with psoriasis and obesity. The company reached a second key milestone ...
Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...
Oklahoma Lawmakers Challenge $1.4 Billion Bond and Rate Hikes by OG&E and PSO at State Supreme Court
Oklahoma lawmakers appeal against utility rate hikes and demand OCC follows state laws for audits after winter storm Uri costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results